Douglas Richman
From Wikipedia, the free encyclopedia
| Douglas D. Richman | |
| Born | February 15, 1943 New York, NY, USA |
|---|---|
| Residence | USA |
| Fields | Virology |
| Institutions | University of California San Diego Veterans Affairs San Diego Health System |
| Known for | HIV resistance, HIV latency |
Douglas D. Richman, MD (born 15 February 1943, New York, NY) is a US medical virologist. Richman has worked primarily in the HIV field over the past twenty years, with major contributions in the areas of resistance and pathogenicity.
Contents |
[edit] Career
Richman received his MD from Stanford University in 1970. After holding positions at the U.S. Public Health Service, National Institute of Allergy and Infectious Diseases and Harvard Medical School, he joined the University of California San Diego (UCSD) in 1976, becoming Professor of Pathology and Medicine (1988) as well as Co-Director (1994) and later Director (2000) of the Center for AIDS Research. As of 2007, he additionally holds the Florence Seeley Riford Chair in AIDS Research there.
He has also held positions at the Veterans Affairs San Diego Health System since 1976, including Director from 1988 to 2007. As of 2007, he holds the position of staff physician.
[edit] Research
Richman's early research was on influenza virus, herpesviruses and hemorrhagic fever viruses, before focusing on HIV in the 1980s. His wide-ranging research in the HIV field has encompassed resistance, viral pathogenicity and host immune responses. He was one of the group of researchers who first demonstrated HIV drug resistance in 1989,[1] and in 1997, his laboratory was also among the first to demonstrate HIV latency.[2]
As of 2007, his research focuses on the natural history and molecular pathogenesis of acute HIV infection, particularly the immune responses to the virus, and viral evolution to evade the immune system.
[edit] Awards, editorships and advisory positions
Awards include the Howard M. Temin Award (1993), Steve Chase Humanitarian Award for Science and Medicine of the Desert AIDS Project (2001) and United States Department of Veterans Affairs Middleton Award (2002).[3]
Richman is one of the founding editors of the academic journal Antiviral Therapy and is Editor-in-Chief of Topics in HIV Medicine, as well as having served on the editorial board of 15 journals. He is a co-editor of the textbook Clinical Virology and editor of Antiviral Drug Resistance.[4][5] He serves on the Vaccine Research Committee of the AIDS Clinical Trials Group and the International AIDS Society panel responsible for publishing international treatment guidelines.
[edit] References
- ^ Larder B, Darby G, Richman DD (1989) HIV with reduced sensitivity to zidovudine isolated during prolonged therapy. Science 243:1731-1734
- ^ Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-95
- ^ Anon. (2003) Dr. Douglas Richman wins VA's Middleton Award. J Investig Med 51(3):127
- ^ Richman DD, ed. Antiviral Drug Resistance. John Wiley & Sons, 1996 (ISBN 0471961205)
- ^ Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology (2nd edn). ASM Press, 2002 (ISBN 1555812260)
